Skip to main content
Levofloxacin decreases bacteremia risk in children with leukemia

Researchers found that levofloxacin prophylaxis is beneficial in reducing bacteremia risk in pediatric patients with relapsed acute lymphoblastic leukemia or acute myeloid leukemia after undergoing intensive chemotherapy; however, the treatment did not lower the risk of bacteremia in children receiving hematopoietic stem cell transplantation. Findings were reported in the Journal of the American Medical Association.

Full Story: